get a key
steadybase-$ company RCEL
account_id none on file
legal_name AVITA Medical, Inc.
ticker RCEL
cik 1762303
domain avitamedical.com
entry_point_account_id none on file
name Avita Medical Inc.
exchange Nasdaq
sector Health Care
calls 12 filings 0 executives 8 family 0
why_nownone on file
calls
The increase in operating expenses is primarily attributable to an increase of $4.6 million in sales and marketing expenses due to employee-related costs, including salaries and benefits, commissions and travel expense collectively as a result of expansion of the Commercial Sales Organization in the second quarter of 2023 and again in the first quarter of this year to support our growing commercial operations.

Nov 8, 2024 / receipt, needs a key / David O'Toole, CFO | earnings call 2024-11-08 | transcript 0b0cea8c-62fb-4d48-b7e9-51d8aab5f87e | chars 13117-13530 | segment 13

The increase in operating expenses is primarily attributable to an increase of $6.3 million in sales and marketing expenses due to employee-related costs, including salaries and benefits, commissions, and travel expense collectively as a result of expansion of the Commercial Sales Organization in the second quarter of 2023 and again in Q1 2024 to support our growing commercial operations.

Aug 9, 2024 / receipt, needs a key / David O'Toole, CFO | earnings call 2024-08-09 | transcript d1984692-2b83-401e-9758-c75b385d3ccb | chars 17866-18257 | segment 18

The increase in operating expense is primarily attributable to an increase of $6.1 million in sales and marketing expenses due to employee-related costs, including salaries and benefits, commissions, and travel expenses, all collectively, as a result of expansion of the Commercial Sales Organization in the second quarter of 2023 to support our growing commercial operations.

May 13, 2024 / receipt, needs a key / David O'Toole, CFO | earnings call 2024-05-13 | transcript ac0fe409-c500-4b85-a185-a00b894ce145 | chars 13722-14098 | segment 13

Lastly, sales and marketing expense increased by $3.9 million, primarily due to employee-related costs, including commissions, travel, and promotion expense as a result of the expansion of our commercial organization in the second quarter of 2023.

Feb 23, 2024 / receipt, needs a key / David O'Toole, CFO | earnings call 2024-02-23 | transcript 5b2a577a-f020-487d-8a00-16a638453229 | chars 12406-12653 | segment 12

The additional sales and marketing costs included approximately $2.9 million in employee-related expenses including wages, commissions, and benefits, $1.4 million in seminars, promotional costs, and travel expenses for both the existing and expanded commercial team, and $400,000 in recruiting expenses.

Aug 10, 2023 / receipt, needs a key / David O'Toole, CFO | earnings call 2023-08-10 | transcript faf81d69-f5a5-4d68-bd0e-a003f9400b42 | chars 12907-13210 | segment 13

The additional sales and marketing costs included approximately $2.9 million in employee-related expenses, including wages, commissions, and benefits, $1.4 million in seminars, promotional costs, and travel expenses for both the existing and expanded commercial team, and $400,000 in recruiting expenses.

Aug 10, 2023 / receipt, needs a key / David, CFO | earnings call 2023-08-10 | transcript faf81d69-f5a5-4d68-bd0e-a003f9400b42 | chars 46429-46733 | segment 47

Higher selling costs are trivial to increase commissions, travel costs, and training events associated with increased sales activity.

Feb 23, 2023 / receipt, needs a key / Sean Deakins, other | earnings call 2023-02-23 | transcript 3aa8b212-d34f-44ce-82be-7356f6e5e860 | chars 10146-10279 | segment 10

It's really the dynamic of what's happening relative to vaccination requirements and some nurses not necessarily wanting to take the vaccination, as well as, as Aaron mentioned earlier, these traveling nurses, they're getting paid substantially more than the regular nursing staff. And then the regular nursing staff are either becoming traveling nurses or taking early retirement because they just don't see the viability or the fairness in the situation.

Nov 8, 2021 / receipt, needs a key / Aaron, other | earnings call 2021-11-08 | transcript 7267c36b-b0ed-4a48-81ae-21c5e5e22072 | chars 23260-23716 | segment 23

This was partially offset with higher travel costs in the current year due to fewer COVID-19-related travel restrictions.

Nov 8, 2021 / receipt, needs a key / Mike Perry, CEO | earnings call 2021-11-08 | transcript 7267c36b-b0ed-4a48-81ae-21c5e5e22072 | chars 16823-16944 | segment 17

So, hi, Matthew. The March things were certainly starting to pick up. And so when I look at the analysis in terms of How many case supports or training were done remotely? There was only, I think, two done in March, and those were not done due to COVID related concerns. They were done simply due to resources and travel, right?

May 13, 2021 / receipt, needs a key / Aaron Liberto, Chief Commercial Officer | earnings call 2021-05-13 | transcript 6a74c70a-0cde-44d4-b01c-821457e1fdba | chars 21760-22088 | segment 21

The decrease in sales and marketing expense in the current quarter is primarily due to reduced travel to burn centers and industry conferences necessitated by COVID-19 related travel restrictions, which was partially offset by higher prior year costs incurred with the resale product launch.

May 13, 2021 / receipt, needs a key / Michael Holder, CFO | earnings call 2021-05-13 | transcript 6a74c70a-0cde-44d4-b01c-821457e1fdba | chars 18565-18856 | segment 18

But they're traveling less and you know so so that I think in general we're feeling good.

Feb 11, 2021 / receipt, needs a key / Erin Liberto, other | earnings call 2021-02-11 | transcript 53b2ac0c-62c9-4d6e-864f-d950c28404f3 | chars 42038-42127 | segment 41

filingsnone on file
executives
Aaron Liberto Chief Commercial Officer - receipt
Cary Vance President and Chief Executive Officer - receipt
David O'Toole CFO linkedin receipt
Jim Corbett CEO - receipt
Lead Independent Director - receipt
Michael Holder CFO - receipt
Mike Holder CFO - receipt
Mike Perry CEO - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled webcast / ir
changes
2026-05-01 President and Chief Executive Officer, appointed sec_8k
2025-10-17 Chief Executive Officer, departed sec_8k
2025-10-17 Director, appointed sec_8k
2025-10-17 Interim Chief Executive Officer, appointed sec_8k
2022-09-30 President, appointed sec_8k
2020-11-06 Chief Financial Officer, departed sec_8k
mcp_package_hint
steadybase-$